College Stock: Penny Stock News

Since The Dean will be teaching the CollegeStock Community about a swine flu-related Ivy League Stock Pick, The Dean wants to clarify commonly asked questions about the production and availability about the Swine Flu (H1N1) pandemic vaccines.

Many people are curious where the vaccines are being produced and The Dean wants the CollegeStock Community to know that regulatory authorities have licensed pandemic vaccines in a number of countries. With many types of medical treatments and devices, the approval process depends on factors such as each country’s regulatory pathway, the type of vaccine/product being licensed, and the stage of the manufacturer’s ability to submit the appropriate information to regulatory authorities such as the FDA.

The World Health Organization (WHO) has estimated that the worldwide production capacity around 3 billion doses per year in the next 12 months, if their efforts were devoted mainly to the pandemic vaccine for swine flu.

But, many sources have reported that the United States is still short of the country’s anticipated need of 40 million vaccine doses, even after receiving another 10 million this week.

The Dean has done his homework and found out that some companies are actually producing vaccines by using chicken eggs but other manufacturers are using cell culture technology for vaccine production.

WHO recommends that all health workers are given first priority for early vaccination to protect themselves and their patients, which will help keep hospitals and clinics up-and-running as the pandemic evolves and potentially worsens as we enter the flu season.

Based on clinical studies determining high risk for severe swine flu illness, WHO suggests that pregnant women, children older than 6 months with chronic medical conditions, health young adults from the age of 15 to 49, and healthy adults 64 years of age and older receive vaccination in this order.

The Dean also found it interesting to learn that as many as 200 million pandemic influenza vaccine doses will be provided to low and middle income families in 95 developing countries around the world. WHO‘s goal is to provide each country with enough vaccine doses to immunize at least 10% of its population. But, deployment of the first suppliers of vaccines have just begun and many countries might not receive the pandemic vaccine until February 2010.

Certainly, The Dean recognizes that swine flu is potentially a dangerous virus that could have negative effects on a global scale. The Dean thinks this provides all the more reason for companies focused on fighting swine flu to see profits over the next six months.

Stay tuned as The Dean will continue to teach the CollegeStock Community about swine flu and the profit potential laying dormant in a company that has yet to go public as an interesting swine flu stock pick.

As with all of The Dean’s Ivy League Stock Picks, The Dean’s Honors Class will learn about the ticker before the rest of the CollegeStock Community. For $9.87/month, can you afford to miss out on The Dean’s next penny stock play?

Your move.